Keyphrases
Tumor
100%
Monoclonal Antibody
100%
Human Tumor Xenograft
100%
Subcutaneous Delivery
100%
Subcutaneous Injection
66%
Specific Antibodies
50%
Gamma Scanning
50%
125I
33%
Intravenous Injection
33%
Iodine-131 (131I)
33%
Choriocarcinoma
33%
Tumor Uptake
33%
Nontumor
33%
Intravenous Delivery
33%
Intralymphatic
33%
Lymph Node
16%
Human Tumors
16%
Tissue Sampling
16%
Tumor-bearing Animals
16%
Nodal Metastasis
16%
Xenograft
16%
Imaging Time
16%
Two-route Scenario
16%
Murine Antibody
16%
Footpad
16%
Hindfoot
16%
Popliteal
16%
Tumor Xenograft
16%
Uptake Ratio
16%
Athymic nude Mice
16%
Tumor Localization
16%
Dual-labeling
16%
Antibody Specificity
16%
Label-only
16%
Human Origins
16%
Choriocarcinoma Cell
16%
Early Imaging
16%
Double-label
16%
Ratio Imaging
16%
Antibody Delivery
16%
Popliteal Region
16%
Subcutaneous Approach
16%
Medicine and Dentistry
Neoplasm
100%
Monoclonal Antibody
100%
Tumor Xenograft
100%
Subcutaneous Injection
36%
Antibodies
27%
Choriocarcinoma
27%
Iodine 125
18%
Iodine 131
18%
Lymph Node
9%
Intravenous Drug Administration
9%
Nodal Metastasis
9%
Xenograft
9%
Scintiscanning
9%
Tumor Localization
9%
Tissue Sampling
9%
Foot Pad
9%
Antibody Specificity
9%